Previous 10 | Next 10 |
China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval PR Newswire HAIKOU, China , Aug. 5, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Compa...
China Pharma to Launch Highly Purified NMN+PQQ Product PR Newswire HAIKOU, China , June 9, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced plans to...
China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue PR Newswire HAIKOU, China , May 14, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical compa...
Gainers: VirTra (VTSI) +83%.Color Star Technology (CSCW) +39%.Performant Financial (PFMT) +36%.VivoPower International (VVPR) +32%.Moxian (MOXC) +26%.Mannatech (MTEX) +23%.Novan (NOVN) +21%.Canaan (CAN) +20%.Lizhi (LIZI) +17%.17 Education & Technology (YQ) +17%.Losers: Elit...
Gainers: Novan (NOVN) +17%, ShockWave Medical (SWAV) +17%, Orphazyme (ORPH) +13%, Moleculin Biotech (MBRX) +14%, Annovis Bio (ANVS) +8%.Losers: Wave Life Sciences (WVE) -30%, Trxade (MEDS) -27%, Universe Pharmaceuticals (UPC)...
AeroCentury ACY -46% after filing petition for Chapter 11Wave Life Sciences WVE -27% on setback for Huntington’s disease trial (updated).Trxade Group MEDS -21% on Q4 earnings release.Vinco Ventures BBIG -16% on providing update to ZASH Global Med...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of several penny stocks are on the rise today as Reddit investors continue to pick out the top ones to take a risk on. Source: John Brueske/Shutterstock.com The gaining interest in penny stocks comes from retai...
An audit opinion issued by an independent accounting firm says that current liabilities and accumulated deficits has raised "substantial doubt" about China Pharma's (CPHI) ability to continue.The company's full-year 2020 results, released Friday, showed GAP EPS of -$0.07 and total revenue of ...
An audit opinion issued by an independent accounting firm says that current liabilities and accumulated deficits have raised "substantial doubt" about China Pharma's (CPHI) ability to continue.The company's full-year 2020 results, released yesterday, showed GAP EPS of -$0.07 and total revenue...
China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results PR Newswire HAIKOU CITY, China , March 26, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE Ameri...
News, Short Squeeze, Breakout and More Instantly...
China Pharma Holdings Inc. Company Name:
CPHI Stock Symbol:
NYSE Market:
China Pharma Holdings Inc. Website:
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.8% to $3.17 on volume of 217,637,164 shares Palantir Technologies Inc. Class A (PLTR) rose 9.9% to $26.16 on volume of 207,386,942 shares PROSHARES TRUST (SQQQ) fell 1.9% to $1...